Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Antigen processing and presentation | R-HSA-1236975 | map04612 | dipivefrine | 3105 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | dipivefrine | 3105 | drug-path |
Apoptosis | R-HSA-109581 | map04210 | dipivefrine | 3105 | drug-path |
RNA polymerase | R-HSA-73864 | map03020 | dipivefrine | 3105 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | dipivefrine | 3105 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | dipivefrine | 3105 | drug-path |
Leukocyte transendothelial migration | R-HSA-8950732 | map04670 | piretanide | 1548887 | drug-path |
RNA polymerase | R-HSA-73864 | map03020 | piretanide | 1548887 | drug-path |
Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | betahistine | 2366 | drug-path |
ECM-receptor interaction | R-HSA-373711 | map04512 | betahistine | 2366 | drug-path |
Gap junction | R-HSA-190861 | map04540 | betahistine | 2366 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | betahistine | 2366 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | betahistine | 2366 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | betahistine | 2366 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | betahistine | 2366 | drug-path |
Focal adhesion | R-HSA-354113 | map04510 | betahistine | 2366 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | betahistine | 2366 | drug-path |
Colorectal cancer | R-HSA-4791275 | map05210 | betahistine | 2366 | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | tropine | 445643 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | chloropyrazine | 33478 | drug-path |